A Breakthrough Therapy in Relapsed Chronic Lymphocytic Leukemia: The Combination of Idelalisib and Rituximab

Postdoc journal
doi 10.14304/surya.jpr.v2n3.6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Postdoc Journal

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy